This research report provides a comprehensive analysis of the Neoantigen Targeted Therapies market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Neoantigen Targeted Therapies market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Neoantigen Targeted Therapies, challenges faced by the industry, and potential opportunities for market players.
The global Neoantigen Targeted Therapies market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Neoantigen Targeted Therapies market presents opportunities for various stakeholders, including Medical Research Institution, Hospital and Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Neoantigen Targeted Therapies market. Additionally, the growing consumer demand present avenues for market expansion.
The global Neoantigen Targeted Therapies market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
Key Features:
The research report on the Neoantigen Targeted Therapies market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Neoantigen Targeted Therapies market.
Market Overview: The report provides a comprehensive overview of the Neoantigen Targeted Therapies market, including its definition, historical development, and current market size. It covers market segmentation by Type e.g., Monotherapy, Combination Therapy, region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Neoantigen Targeted Therapies market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Neoantigen Targeted Therapies markets trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Neoantigen Targeted Therapies market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Neoantigen Targeted Therapies market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Neoantigen Targeted Therapies market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Neoantigen Targeted Therapies market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Neoantigen Targeted Therapies, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Neoantigen Targeted Therapies market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Neoantigen Targeted Therapies market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Monotherapy
Combination Therapy
Market segment by Application
Medical Research Institution
Hospital and Clinic
Other
Global Neoantigen Targeted Therapies Market Segment Percentages, By Region and Country, 2023 %
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Bavarian Nordic
Genocea Biosciences
Gradalis
Immunicum
Immunovative Therapies
Iovance Biotherapeutics
MediGene
Neon Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neoantigen Targeted Therapies, market overview.
Chapter 2: Global Neoantigen Targeted Therapies market size in revenue.
Chapter 3: Detailed analysis of Neoantigen Targeted Therapies company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neoantigen Targeted Therapies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Neoantigen Targeted Therapies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neoantigen Targeted Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neoantigen Targeted Therapies Overall Market Size
2.1 Global Neoantigen Targeted Therapies Market Size: 2023 VS 2030
2.2 Global Neoantigen Targeted Therapies Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neoantigen Targeted Therapies Players in Global Market
3.2 Top Global Neoantigen Targeted Therapies Companies Ranked by Revenue
3.3 Global Neoantigen Targeted Therapies Revenue by Companies
3.4 Top 3 and Top 5 Neoantigen Targeted Therapies Companies in Global Market, by Revenue in 2023
3.5 Global Companies Neoantigen Targeted Therapies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neoantigen Targeted Therapies Players in Global Market
3.6.1 List of Global Tier 1 Neoantigen Targeted Therapies Companies
3.6.2 List of Global Tier 2 and Tier 3 Neoantigen Targeted Therapies Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neoantigen Targeted Therapies Market Size Markets, 2023 & 2030
4.1.2 Monotherapy
4.1.3 Combination Therapy
4.2 By Type - Global Neoantigen Targeted Therapies Revenue & Forecasts
4.2.1 By Type - Global Neoantigen Targeted Therapies Revenue, 2019-2024
4.2.2 By Type - Global Neoantigen Targeted Therapies Revenue, 2025-2030
4.2.3 By Type - Global Neoantigen Targeted Therapies Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neoantigen Targeted Therapies Market Size, 2023 & 2030
5.1.2 Medical Research Institution
5.1.3 Hospital and Clinic
5.1.4 Other
5.2 By Application - Global Neoantigen Targeted Therapies Revenue & Forecasts
5.2.1 By Application - Global Neoantigen Targeted Therapies Revenue, 2019-2024
5.2.2 By Application - Global Neoantigen Targeted Therapies Revenue, 2025-2030
5.2.3 By Application - Global Neoantigen Targeted Therapies Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Neoantigen Targeted Therapies Market Size, 2023 & 2030
6.2 By Region - Global Neoantigen Targeted Therapies Revenue & Forecasts
6.2.1 By Region - Global Neoantigen Targeted Therapies Revenue, 2019-2024
6.2.2 By Region - Global Neoantigen Targeted Therapies Revenue, 2025-2030
6.2.3 By Region - Global Neoantigen Targeted Therapies Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Neoantigen Targeted Therapies Revenue, 2019-2030
6.3.2 US Neoantigen Targeted Therapies Market Size, 2019-2030
6.3.3 Canada Neoantigen Targeted Therapies Market Size, 2019-2030
6.3.4 Mexico Neoantigen Targeted Therapies Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Neoantigen Targeted Therapies Revenue, 2019-2030
6.4.2 Germany Neoantigen Targeted Therapies Market Size, 2019-2030
6.4.3 France Neoantigen Targeted Therapies Market Size, 2019-2030
6.4.4 U.K. Neoantigen Targeted Therapies Market Size, 2019-2030
6.4.5 Italy Neoantigen Targeted Therapies Market Size, 2019-2030
6.4.6 Russia Neoantigen Targeted Therapies Market Size, 2019-2030
6.4.7 Nordic Countries Neoantigen Targeted Therapies Market Size, 2019-2030
6.4.8 Benelux Neoantigen Targeted Therapies Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Neoantigen Targeted Therapies Revenue, 2019-2030
6.5.2 China Neoantigen Targeted Therapies Market Size, 2019-2030
6.5.3 Japan Neoantigen Targeted Therapies Market Size, 2019-2030
6.5.4 South Korea Neoantigen Targeted Therapies Market Size, 2019-2030
6.5.5 Southeast Asia Neoantigen Targeted Therapies Market Size, 2019-2030
6.5.6 India Neoantigen Targeted Therapies Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Neoantigen Targeted Therapies Revenue, 2019-2030
6.6.2 Brazil Neoantigen Targeted Therapies Market Size, 2019-2030
6.6.3 Argentina Neoantigen Targeted Therapies Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neoantigen Targeted Therapies Revenue, 2019-2030
6.7.2 Turkey Neoantigen Targeted Therapies Market Size, 2019-2030
6.7.3 Israel Neoantigen Targeted Therapies Market Size, 2019-2030
6.7.4 Saudi Arabia Neoantigen Targeted Therapies Market Size, 2019-2030
6.7.5 UAE Neoantigen Targeted Therapies Market Size, 2019-2030
7 Neoantigen Targeted Therapies Companies Profiles
7.1 Bavarian Nordic
7.1.1 Bavarian Nordic Company Summary
7.1.2 Bavarian Nordic Business Overview
7.1.3 Bavarian Nordic Neoantigen Targeted Therapies Major Product Offerings
7.1.4 Bavarian Nordic Neoantigen Targeted Therapies Revenue in Global Market 2019-2024
7.1.5 Bavarian Nordic Key News & Latest Developments
7.2 Genocea Biosciences
7.2.1 Genocea Biosciences Company Summary
7.2.2 Genocea Biosciences Business Overview
7.2.3 Genocea Biosciences Neoantigen Targeted Therapies Major Product Offerings
7.2.4 Genocea Biosciences Neoantigen Targeted Therapies Revenue in Global Market 2019-2024
7.2.5 Genocea Biosciences Key News & Latest Developments
7.3 Gradalis
7.3.1 Gradalis Company Summary
7.3.2 Gradalis Business Overview
7.3.3 Gradalis Neoantigen Targeted Therapies Major Product Offerings
7.3.4 Gradalis Neoantigen Targeted Therapies Revenue in Global Market 2019-2024
7.3.5 Gradalis Key News & Latest Developments
7.4 Immunicum
7.4.1 Immunicum Company Summary
7.4.2 Immunicum Business Overview
7.4.3 Immunicum Neoantigen Targeted Therapies Major Product Offerings
7.4.4 Immunicum Neoantigen Targeted Therapies Revenue in Global Market 2019-2024
7.4.5 Immunicum Key News & Latest Developments
7.5 Immunovative Therapies
7.5.1 Immunovative Therapies Company Summary
7.5.2 Immunovative Therapies Business Overview
7.5.3 Immunovative Therapies Neoantigen Targeted Therapies Major Product Offerings
7.5.4 Immunovative Therapies Neoantigen Targeted Therapies Revenue in Global Market 2019-2024
7.5.5 Immunovative Therapies Key News & Latest Developments
7.6 Iovance Biotherapeutics
7.6.1 Iovance Biotherapeutics Company Summary
7.6.2 Iovance Biotherapeutics Business Overview
7.6.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Major Product Offerings
7.6.4 Iovance Biotherapeutics Neoantigen Targeted Therapies Revenue in Global Market 2019-2024
7.6.5 Iovance Biotherapeutics Key News & Latest Developments
7.7 MediGene
7.7.1 MediGene Company Summary
7.7.2 MediGene Business Overview
7.7.3 MediGene Neoantigen Targeted Therapies Major Product Offerings
7.7.4 MediGene Neoantigen Targeted Therapies Revenue in Global Market 2019-2024
7.7.5 MediGene Key News & Latest Developments
7.8 Neon Therapeutics
7.8.1 Neon Therapeutics Company Summary
7.8.2 Neon Therapeutics Business Overview
7.8.3 Neon Therapeutics Neoantigen Targeted Therapies Major Product Offerings
7.8.4 Neon Therapeutics Neoantigen Targeted Therapies Revenue in Global Market 2019-2024
7.8.5 Neon Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Neoantigen Targeted Therapies Market Opportunities & Trends in Global Market
Table 2. Neoantigen Targeted Therapies Market Drivers in Global Market
Table 3. Neoantigen Targeted Therapies Market Restraints in Global Market
Table 4. Key Players of Neoantigen Targeted Therapies in Global Market
Table 5. Top Neoantigen Targeted Therapies Players in Global Market, Ranking by Revenue 2023
Table 6. Global Neoantigen Targeted Therapies Revenue by Companies, US$, Mn, 2019-2024
Table 7. Global Neoantigen Targeted Therapies Revenue Share by Companies, 2019-2024
Table 8. Global Companies Neoantigen Targeted Therapies Product Type
Table 9. List of Global Tier 1 Neoantigen Targeted Therapies Companies, Revenue US$, Mn in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neoantigen Targeted Therapies Companies, Revenue US$, Mn in 2023 and Market Share
Table 11. By Type – Global Neoantigen Targeted Therapies Revenue, US$, Mn, 2023 & 2030
Table 12. By Type - Neoantigen Targeted Therapies Revenue in Global US$, Mn, 2019-2024
Table 13. By Type - Neoantigen Targeted Therapies Revenue in Global US$, Mn, 2025-2030
Table 14. By Application – Global Neoantigen Targeted Therapies Revenue, US$, Mn, 2023 & 2030
Table 15. By Application - Neoantigen Targeted Therapies Revenue in Global US$, Mn, 2019-2024
Table 16. By Application - Neoantigen Targeted Therapies Revenue in Global US$, Mn, 2025-2030
Table 17. By Region – Global Neoantigen Targeted Therapies Revenue, US$, Mn, 2023 & 2030
Table 18. By Region - Global Neoantigen Targeted Therapies Revenue US$, Mn, 2019-2024
Table 19. By Region - Global Neoantigen Targeted Therapies Revenue US$, Mn, 2025-2030
Table 20. By Country - North America Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2024
Table 21. By Country - North America Neoantigen Targeted Therapies Revenue, US$, Mn, 2025-2030
Table 22. By Country - Europe Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2024
Table 23. By Country - Europe Neoantigen Targeted Therapies Revenue, US$, Mn, 2025-2030
Table 24. By Region - Asia Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2024
Table 25. By Region - Asia Neoantigen Targeted Therapies Revenue, US$, Mn, 2025-2030
Table 26. By Country - South America Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2024
Table 27. By Country - South America Neoantigen Targeted Therapies Revenue, US$, Mn, 2025-2030
Table 28. By Country - Middle East & Africa Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2024
Table 29. By Country - Middle East & Africa Neoantigen Targeted Therapies Revenue, US$, Mn, 2025-2030
Table 30. Bavarian Nordic Company Summary
Table 31. Bavarian Nordic Neoantigen Targeted Therapies Product Offerings
Table 32. Bavarian Nordic Neoantigen Targeted Therapies Revenue US$, Mn & 2019-2024
Table 33. Bavarian Nordic Key News & Latest Developments
Table 34. Genocea Biosciences Company Summary
Table 35. Genocea Biosciences Neoantigen Targeted Therapies Product Offerings
Table 36. Genocea Biosciences Neoantigen Targeted Therapies Revenue US$, Mn & 2019-2024
Table 37. Genocea Biosciences Key News & Latest Developments
Table 38. Gradalis Company Summary
Table 39. Gradalis Neoantigen Targeted Therapies Product Offerings
Table 40. Gradalis Neoantigen Targeted Therapies Revenue US$, Mn & 2019-2024
Table 41. Gradalis Key News & Latest Developments
Table 42. Immunicum Company Summary
Table 43. Immunicum Neoantigen Targeted Therapies Product Offerings
Table 44. Immunicum Neoantigen Targeted Therapies Revenue US$, Mn & 2019-2024
Table 45. Immunicum Key News & Latest Developments
Table 46. Immunovative Therapies Company Summary
Table 47. Immunovative Therapies Neoantigen Targeted Therapies Product Offerings
Table 48. Immunovative Therapies Neoantigen Targeted Therapies Revenue US$, Mn & 2019-2024
Table 49. Immunovative Therapies Key News & Latest Developments
Table 50. Iovance Biotherapeutics Company Summary
Table 51. Iovance Biotherapeutics Neoantigen Targeted Therapies Product Offerings
Table 52. Iovance Biotherapeutics Neoantigen Targeted Therapies Revenue US$, Mn & 2019-2024
Table 53. Iovance Biotherapeutics Key News & Latest Developments
Table 54. MediGene Company Summary
Table 55. MediGene Neoantigen Targeted Therapies Product Offerings
Table 56. MediGene Neoantigen Targeted Therapies Revenue US$, Mn & 2019-2024
Table 57. MediGene Key News & Latest Developments
Table 58. Neon Therapeutics Company Summary
Table 59. Neon Therapeutics Neoantigen Targeted Therapies Product Offerings
Table 60. Neon Therapeutics Neoantigen Targeted Therapies Revenue US$, Mn & 2019-2024
Table 61. Neon Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Neoantigen Targeted Therapies Segment by Type in 2023
Figure 2. Neoantigen Targeted Therapies Segment by Application in 2023
Figure 3. Global Neoantigen Targeted Therapies Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Neoantigen Targeted Therapies Market Size: 2023 VS 2030 US$, Mn
Figure 6. Global Neoantigen Targeted Therapies Revenue, 2019-2030 US$, Mn
Figure 7. The Top 3 and 5 Players Market Share by Neoantigen Targeted Therapies Revenue in 2023
Figure 8. By Type - Global Neoantigen Targeted Therapies Revenue Market Share, 2019-2030
Figure 9. By Application - Global Neoantigen Targeted Therapies Revenue Market Share, 2019-2030
Figure 10. By Type - Global Neoantigen Targeted Therapies Revenue, US$, Mn, 2023 & 2030
Figure 11. By Type - Global Neoantigen Targeted Therapies Revenue Market Share, 2019-2030
Figure 12. By Application - Global Neoantigen Targeted Therapies Revenue, US$, Mn, 2023 & 2030
Figure 13. By Application - Global Neoantigen Targeted Therapies Revenue Market Share, 2019-2030
Figure 14. By Region - Global Neoantigen Targeted Therapies Revenue Market Share, 2019-2030
Figure 15. By Country - North America Neoantigen Targeted Therapies Revenue Market Share, 2019-2030
Figure 16. US Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 17. Canada Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 18. Mexico Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 19. By Country - Europe Neoantigen Targeted Therapies Revenue Market Share, 2019-2030
Figure 20. Germany Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 21. France Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 22. U.K. Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 23. Italy Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 24. Russia Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 25. Nordic Countries Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 26. Benelux Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 27. By Region - Asia Neoantigen Targeted Therapies Revenue Market Share, 2019-2030
Figure 28. China Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 29. Japan Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 30. South Korea Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 31. Southeast Asia Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 32. India Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 33. By Country - South America Neoantigen Targeted Therapies Revenue Market Share, 2019-2030
Figure 34. Brazil Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 35. Argentina Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 36. By Country - Middle East & Africa Neoantigen Targeted Therapies Revenue Market Share, 2019-2030
Figure 37. Turkey Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 38. Israel Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 39. Saudi Arabia Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 40. UAE Neoantigen Targeted Therapies Revenue, US$, Mn, 2019-2030
Figure 41. Bavarian Nordic Neoantigen Targeted Therapies Revenue Year Over Year Growth US$, Mn & 2019-2024
Figure 42. Genocea Biosciences Neoantigen Targeted Therapies Revenue Year Over Year Growth US$, Mn & 2019-2024
Figure 43. Gradalis Neoantigen Targeted Therapies Revenue Year Over Year Growth US$, Mn & 2019-2024
Figure 44. Immunicum Neoantigen Targeted Therapies Revenue Year Over Year Growth US$, Mn & 2019-2024
Figure 45. Immunovative Therapies Neoantigen Targeted Therapies Revenue Year Over Year Growth US$, Mn & 2019-2024
Figure 46. Iovance Biotherapeutics Neoantigen Targeted Therapies Revenue Year Over Year Growth US$, Mn & 2019-2024
Figure 47. MediGene Neoantigen Targeted Therapies Revenue Year Over Year Growth US$, Mn & 2019-2024
Figure 48. Neon Therapeutics Neoantigen Targeted Therapies Revenue Year Over Year Growth US$, Mn & 2019-2024
